Brazilian Journal of Biological Sciences (ISSN 2358-2731)



Home Archive v. 4, No. 7 (2017) Ajayi

 

Vol. 4, No. 7, p. 45-52 - Jun. 30, 2017

 

Aqueous extract of bitter leaf Vernonia amygdalina Delile (Asterales: Asteraceae) ameliorates testosterone-induced benign prostatic hyperplasia (BPH) in Wistar rats



Abayomi Ajayi , Titilayo Ige , Nich Arawa Ude , Olusegun Dare Omotoso Gbenga Olorunshola Alege , John Oluwagbenga Balogun , Ekanem Ikanna Asuquo and Akpovughaye Taiga

Abstract
Benign prostatic hyperplasia (BPH) is an age-dependent condition involving prostate enlargement which may lead to lower urinary tract symptoms (LUTS). This study was designed to study the ameliorative effect of the aqueous extract of bitter leaf Vernonia amygdalina Delile (Asterales: Asteraceae) on testosterone-induced BPH in a rat model. Thirty adult male Wister rats were randomly divided into six groups (A to F), with BPH induced through a single subcutaneous injection of 5 mg/kg of testosterone propionate (TP) and Vernonia amygdalina administered in various doses through oral gavage for 14 days. Group A (control) was administered with distilled water only, group B with 5 mg/kg of TP only, group C with 5 g/mL of V. amygdalina only, group D with 5 mg/kg of TP and 5 g/mL of V. amygdalina, group E with 5 mg/kg of TP and 7.5 g/mL of V. amygdalina and group F with 5 mg/kg of TP and 10 g/ml of V. amygdalina. Results show that testosterone caused histological changes that are similar to the presentation of BPH in the prostate. Aqueous extract of V. amygdalina was observed to ameliorate testosterone-induced histological changes and prostatic parameters especially at higher concentration. This suggests that bitter leaf could be a candidate herb for the treatment of BPH.


Keywords
Benign prostatic hyperplasia; Testosterone; Bitter leaf; Vernonia amygdalina; Prostate gland.

DOI
10.21472/bjbs.040706

Full text
PDF

References
Abraham, K.; Ajayi, A. Benign prostatic hyperplasia: role of estrogen and putative therapeutic effect of selective estrogen receptor modulators. Proceedings of the Physiological Society of Nigeria, 28, 2014. Available from: <http://www.physoc.org/proceedings/abstract/Proc Physiol Soc 31C55>. Accessed on: Feb. 20, 2017.

Chan, S. W. Pathology and medical therapy of benign prostatic hyperplasia. The Hong Kong Medical Diary, v. 16, No. 6, p. 4-8, 2011. https://dx.doi.org/10.4236/ojmm.2015.51004

Chou, C.-L. Current medical treatment for benign prostatic hyperplasia/lower urinary tract symptoms. Incont. Pelvic Floor Dysfunct, v. 1, No. 2, Suppl. 2, p. 15-19, 2007. Available from: <http://www.tcs.org.tw/issue/folder/1_2suppl/1-suppl 2-15-19.pdf>. Accessed on: Feb. 20, 2017.

Dhingra, N.; Bhagwat, D. Benign prostatic hyperplasia: an overview of existing treatment. Indian Journal of Pharmacology, v. 43, No. 1, p. 6-12, 2011. https://dx.doi.org/10.4103/0253-7613.75657

Eisenberg, D. M.; Kessler, R. C.; Foster, C.; Norlock, F. E., Calkins, D. R.; Delbanco, T. L. Unconventional medicine in the United States. New England Journal of Medicine, v. 328, p. 246-252, 1993. https://dx.doi.org/10.1056/NEJM199301283280406

Eleyinmi, A. F.; Sporns, P.; Bressler, D. C. Nutritional composition of Gongronema latifolium and Vernonia amygdalina. Nutr. Food Sci., v. 38, p. 99-109, 2008. https://dx.doi.org/10.1108/00346650810862975

Erasto, P.; Grierson, D. S.; Afolayan, A. J. Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J. Ethnopharmacol., v. 106, p. 117-120, 2006. https://dx.doi.org/10.1016/j.jep.2005.12.016

Hutchinson, J.; Dalziel, M. J. Floral of West Tropical Africa. 2. ed. London: Crown Agent for Overseas Government and Administrations, 1963. v. 2. p. 225-297.

Ijeh, I. I.; Ejike, C. E. C. C. Current perspectives on the medicinal potentials of Vernonia amygdalina Del. Journal of Medicinal Plants Research, v. 5, No. 7, p. 1051-1061, 2011. Available from: <http://www.academicjournals.org/article/article1380529017_Ijeh and Ejike.pdf>. Accessed on: Feb. 20, 2017.

Kapoor, A. Benign Prostatic Hyperplasia (BPH) management in the primary care setting. The Canadian Journal of Urology, v. 19, No. 1, p. 10-17, 2012. Available from: <http://www.canjurol.com/html/free-articles/V19I5S1F-03-DrKapoor.pdf>. Accessed on: Feb. 20, 2017.

Lasekan, O. O.; Lasekan, W. O.; Babalola, J. O. Effect of Vernonia amygdalina (bitter leaf) extract on brewing qualities and amino acid profiles of stout drink from sorghum and barley malts. Food Chemistry, v. 64, p. 507-510, 1998. https://dx.doi.org/10.1016/S0308-8146(98)00148-4

Okoh, I. A.; Babalola, G. O.; Ilori, M. O. Effect of methanol extract of Vernonia amygdalina on malting and brewing properties of sorghum. Tech. Q. Master Brew. Assoc. Am., v. 32, No. 1, p. 11-14, 1995.

Okoli, R. I.; Aigbe, O.; Ohafu-Obode, J. O.; Mensah, J. K. Medicinal herbs used for managing some common ailments among Esan People Edo State, Nigeria. Pakistan Journal of Nutrition, v. 6, No. 5, p. 470-490, 2007. https://dx.doi.org/10.3923/pjn.2007.490.496

Oluwalana, S. A.; Adekunle, M. F. Forest plant roots in household nutrition and health care in Abeokuta, Ogun State, Nigeria. J. Trop. for Resources, v. 1, p. 120-136, 1998.

Onyechi, O.; Elom, S.O.; Chukwunonso E. C. C. Prostate problems with aging, prevention and treatment prospects. Unique, p. 45-50, 2012.

Rice-Evans, C. A.; Miller, N. J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., v. 20, p. 933-956, 1996. https://doi.org/10.1016/0891-5849(95)02227-9

Suzuki, K. Epidemiology of prostate cancer and benign prostatic hyperplasia. Journal of Medical Association of Japan, v. 52, No. 6, p. 478-483, 2009. Available from: <https://www.med.or.jp/english/journal/pdf/2009_06/478_483.pdf. Accessed on: Feb. 20, 2017.